scispace - formally typeset
C

Christopher S. McKee

Researcher at Newcastle University

Publications -  4
Citations -  278

Christopher S. McKee is an academic researcher from Newcastle University. The author has contributed to research in topics: Autophagy & Apoptosis. The author has an hindex of 4, co-authored 4 publications receiving 219 citations.

Papers
More filters
Journal ArticleDOI

Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.

TL;DR: It is suggested that the regulation of Mcl‐1 expression by BRAF signalling is increased by oncogenic activation of BRAF, revealing a mechanism of apoptotic resistance which may be overcome by the use of more specifically targeted M cl‐1 inhibitors.
Journal ArticleDOI

Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.

TL;DR: Combined AKT inhibition and chloroquine treatment of MET 4 cSCC cells resulted in significantly enhanced inhibition of cell viability and apoptosis induced by clinically achievable concentrations of docetaxel (P < 0.001), indicating that inhibition of both autophagy and AKT represents an effective and viable therapeutic strategy to increase the cytotoxicity ofDocetaxe for the treatment of advanced cS CC.